Y041-1857 Screening compound: 6-{2-[3-(4-bromophenyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl]acetamido}hexanoic acid

Y041-1857 Screening compound: 6-{2-[3-(4-bromophenyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl]acetamido}hexanoic acid
Y041-1857 Screening compound: 6-{2-[3-(4-bromophenyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl]acetamido}hexanoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound Y041-1857
6-{2-[3-(4-bromophenyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl]acetamido}hexanoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y041-1857

Molecular Formula

C26H24BrNO6 (C26 H24 BrNO6)

Compound Name

6-{2-[3-(4-bromophenyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl]acetamido}hexanoic acid

IUPAC name

6-{2-[3-(4-bromophenyl)-5-methyl-7-oxo-7H-furo[32-g]chromen-6-yl]acetamido}hexanoic acid

SMILES

CC(c(c(O1)c2)cc3c2occ3-c(cc2)ccc2Br)=C(CC(NCCCCCC(O)=O)=O)C1=O

InChI

InChI=1S/C26H24BrNO6/c1-15-18-11-20-21(16-6-8-17(27)9-7-16)14-33-22(20)13-23(18)34-26(32)19(15)12-24(29)28-10-4-2-3-5-25(30)31/h6-9,11,13-14H,2-5,10,12H2,1H3,(H,28,29)(H,30,31)

InChI Key

XPALLFOGSSWDNK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06495538

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

526.38

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.328

Distribution Coefficient, logD

1.499

Water Solubility, LogSw

-4.15

Polar Surface Area

83.145

Acid Dissociation Constant (pKa)

4.57

Base Dissociation Constant (pKb)

3.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

Y041-1857 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with Y041-1857 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y041-1857?
Check Price and Availability of Y041-1857, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y041-1857 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y041-1857
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y041-1857
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y041-1857 available by request